EN6

EN6 has been studied in 3 papers since 2025: none in people yet, 3 in animals; 2 in the past year. The research so far is in animals.

Intervention

3 papers study it2 findingsUpdated

PubChem

See all 2 papers on EN6

At a glance

The findings reach mice, none yet in people. 2 independent labs in 2 countries.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 2 independent labs in 2 countries
  • Funders: Astellas Foundation for Research on Metabolic Disorders and others
  • Animals2

What did studies of EN6 find?

2

Studies of EN6 measured 2 outcomes: cellular senescence and pancreatic cancer.

Cellular senescence

downin mice1

1 study
  1. EN6 decreases cellular senescence in Rnasek-/- mouse embryos.

    Animalsin Rnasek-/- mouse embryos

More on Cellular senescence

Pancreatic cancer

downin mice1

1 study
  1. EN6 prevents pancreatic cancer in xenograft and Kras mutant mouse models.

    Animalsin xenograft and Kras mutant mouse models

More on Pancreatic cancer

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months